| 1 |
Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial
David A. Margolis, Cynthia C Brinson, Graham H.R. Smith et al. · The Lancet Infectious Diseases
|
19 Jul 2015 |
205 |
| 2 |
Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial
David Alain Wohl, Yazdan Yazdanpanah, Axel Baumgarten et al. · The Lancet HIV
|
8 May 2019 |
169 |
| 3 |
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials
Chloe M. Orkin et al. · The Lancet HIV
Open access |
Jun 2020 |
144 |
| 4 |
Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study
Catherine Orrell et al. · The Lancet HIV
106 authors |
18 Jul 2017 |
118 |
| 5 |
Sex-Based Outcomes of Darunavir–Ritonavir Therapy
Judith S. Currier, Dawn Averitt Bridge, Debbie Hagins et al. · Annals of Internal Medicine
Open access |
21 Sep 2010 |
85 |
| 6 |
Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 study
Kathleen Squires, Cissy M Kityo, Sally Hodder et al. · The Lancet HIV
Open access |
29 May 2016 |
84 |
| 7 |
Dolutegravir versus Placebo in Subjects Harbouring HIV-1 with Integrase Inhibitor Resistance Associated Substitutions: 48-Week Results from VIKING-4, a Randomized Study
Bisher Akil, Gary Blick, Debbie P. Hagins et al. · Antiviral Therapy
|
Apr 2014 |
80 |
| 8 |
Health effects of long-term mercury exposure among chloralkali plant workers
Howard Frumkin, Richard Letz, Phillip L. Williams et al. · American Journal of Industrial Medicine
|
2001 |
77 |
| 9 |
Forty‐eight‐week efficacy and safety and early CNS tolerability of doravirine (MK‐1439), a novel NNRTI, with TDF/FTC in ART‐naive HIV‐positive patients
Josep M. Gatell, Javier O Morales‐Ramirez, Debbie P. Hagins et al. · Journal of the International AIDS Society
Open access |
Nov 2014 |
60 |
| 10 |
Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial
Cissy M Kityo, Debbie P. Hagins, Ellen Koenig et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes
Open access |
14 Oct 2019 |
58 |
| 11 |
A systematic review on the effectiveness of diet and exercise in the management of obesity
Iyanu Victoria Olateju, Taiwo Opaleye-Enakhimion, Jennifer E. Udeogu et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews
Review |
Apr 2023 |
52 |
| 12 |
Recruitment and Retention of Diverse Populations in Antiretroviral Clinical Trials: Practical Applications from the Gender, Race And Clinical Experience Study
Ron Falcon, Dawn Averitt Bridge, Judith S. Currier et al. · Journal of Women s Health
Open access |
10 Jun 2011 |
49 |
| 13 |
Objective Evidence of Reflux Control After Magnetic Sphincter Augmentation
Brian E. Louie, C. Daniel Smith, Christopher C. Smith et al. · Annals of Surgery
|
24 Apr 2018 |
48 |
| 14 |
Switching to coformulated rilpivirine ( RPV ), emtricitabine ( FTC ) and tenofovir alafenamide from either RPV , FTC and tenofovir disoproxil fumarate ( TDF ) or efavirenz, FTC and TDF : 96‐week results from two randomized clinical trials
D Hagins, Chloe M. Orkin, ES Daar et al. · HIV Medicine
Open access |
12 Aug 2018 |
47 |
| 15 |
Early detection and prevention of lung cancer
Gail Shaw Wright, Michael E. Gruidl · Current Opinion in Oncology
|
Mar 2000 |
45 |
| 16 |
Peripheral nerves are pathologically small in cerebellar ataxia neuropathy vestibular areflexia syndrome: a controlled ultrasound study
Luciana Pelosi, Eoin Mulroy, Ruth Leadbetter et al. · European Journal of Neurology
|
10 Jan 2018 |
44 |
| 17 |
Communicating about Youth’s Sun Exposure Risk to Soccer Coaches and Parents: A Pilot Study in Georgia
Roxanne L Parrott, Ashley Paige Duggan, Jeff Cremo et al. · Health Education & Behavior
|
Jun 1999 |
41 |
| 18 |
Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial
Anthony Mills, Giuliano Rizzardini, Moti N. Ramgopal et al. · The Lancet HIV
|
8 May 2024 |
35 |
| 19 |
Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults
Scott Lee Letendre, Anthony Mills, Debbie P. Hagins et al. · Journal of Antimicrobial Chemotherapy
Open access |
22 Nov 2019 |
32 |
| 20 |
Outbreak of Tuberculosis Associated with a Floating Card Game in the Rural South: Lessons for Tuberculosis Contact Investigations
NAOMI N. BOCK, John P. Mallory, Nell Mobley et al. · Clinical Infectious Diseases
Open access |
Nov 1998 |
31 |
| 21 |
A Cost‐effectiveness Analysis of Propofol versus Midazolam for Procedural Sedation in the Emergency Department
Corinne Michèle Hohl, Bohdan Nosyk, Mohsen Sadatsafavi et al. · Academic Emergency Medicine
Open access |
2008 |
31 |
| 22 |
Audit of severe acute maternal morbidity describing reasons for transfer and potential preventability of admissions to ICU
Beverley A. LAWTON, Leona Wilson, Richard Dinsdale et al. · Australian and New Zealand Journal of Obstetrics and Gynaecology
|
28 Jul 2010 |
30 |
| 23 |
Solarization and Chemical Alternatives to Methyl Bromide for Preplant Soil Treatment of Strawberries
Mark W. Rieger, Gerard W. Krewer, Pamela M. Lewis · HortTechnology
Open access |
2001 |
28 |
| 24 |
Doravirine dose Selection and 96-Week Safety and Efficacy versus Efavirenz in Antiretroviral Therapy-Naive Adults with HIV-1 Infection in a Phase IIb Trial
José M. Gatell et al. · Antiviral Therapy
|
Aug 2018 |
25 |
| 25 |
An evaluation of “groups for parents” a standardized format encompassing both behavior modification and humanistic methods
Orin W. Sadler, Terence Seyden, Billy Howe et al. · Journal of Community Psychology
|
Apr 1976 |
19 |
| 26 |
Brief Report: Efficacy and Safety of Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (E/C/F/TAF) in Virologically Suppressed Women
Sally Hodder, Kathleen Squires, Cissy M Kityo et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes
Open access |
23 Feb 2018 |
18 |
| 27 |
Recommendations and Administration of the HPV Vaccine to 11- to 12-Year-Old Girls and Boys
John S. Luque, Yelena N. Tarasenko, Betty T. Dixon et al. · Journal of Lower Genital Tract Disease
|
14 Mar 2014 |
18 |
| 28 |
Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) Fixed-Dose Combination (FDC) Compared With Ritonavir-Boosted Atazanavir (ATV/r) Plus Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC) in Treatment-Naive Women With Human Immunodeficiency Virus (HIV)-1 Infection (ARIA Study): Analyses by Race Subgroups
Debbie P. Hagins, Craig Dietz, Mamta K. Jain et al. · Open Forum Infectious Diseases
Open access |
2016 |
15 |
| 29 |
Asthma and Respiratory Foundation NZ child and adolescent asthma guidelines: a quick reference guide.
Innes Asher, David G. McNamara, Cheryl Davies et al. · PubMed
|
Dec 2017 |
13 |
| 30 |
Impact of School Flu Vaccine Program on Student Absences
Sara S. Plaspohl, Betty T. Dixon, James A. Streater et al. · The Journal of School Nursing
|
30 Apr 2013 |
12 |
| 31 |
Impact of treatment adherence on efficacy of dolutegravir plus lamivudine and dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: pooled analysis of the GEMINI-1 and GEMINI-2 clinical studies
Mounir Ait‐Khaled, Juan Sierra Madero, Vicente Estrada et al. · HIV Research & Clinical Practice
Open access |
16 Dec 2021 |
11 |
| 32 |
Livestock-related injuries in the Midland region of New Zealand.
Mischa Tosswill, Matthew James Roskruge, Alastair David Smith et al. · PubMed
|
5 Oct 2018 |
11 |
| 33 |
Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIV
Eric S. Daar, Chloe M. Orkin, Paul Edward Sax et al. · AIDS Research and Therapy
Open access |
7 Apr 2025 |
9 |
| 34 |
Community advisory boards as implementation strategies to center partner and patient voice in community health centers
Rebekka M. Lee, Kamini Mallick, James G. Daly et al. · Journal of Clinical and Translational Science
Open access |
17 Dec 2024 |
8 |
| 35 |
Patient-Reported Outcomes in the Phase III BRIGHTE Trial of the HIV-1 Attachment Inhibitor Prodrug Fostemsavir in Heavily Treatment-Experienced Individuals
Sarah‐Jane Anderson, Miranda I. Murray, David F Cella et al. · Patient
Open access |
28 Jun 2021 |
8 |
| 36 |
Final efficacy and safety of twice-yearly subcutaneous lenacapavir in treatment-naive people with HIV
Debbie P. Hagins, Mezgebe Berhe, Gordon E. Crofoot et al. · AIDS
|
6 Oct 2025 |
7 |
| 37 |
LB4. A Phase 3, Randomized, Controlled Clinical Trial of Bictegravir in a Fixed-Dose Combination, B/F/TAF, vs. ABC/DTG/3TC in Treatment-Naïve Adults at Week 96
David Alain Wohl, Yazdan Yazdanpanah, Axel Baumgarten et al. · Open Forum Infectious Diseases
Open access |
Nov 2018 |
7 |
| 38 |
Building Capacity to Support and Study QI in Local Georgia Public Health Systems
William C. Livingood, Nandi A. Marshall, Angela H. Peden et al. · UKnowledge (University of Kentucky)
Open access |
2012 |
7 |
| 39 |
1985. A Prospective, Randomized Trial to Assess a Protease Inhibitor–based Regimen Switch Strategy to Manage Integrase Inhibitor–related Weight Gain
William R. Short, Moti N. Ramgopal, Debbie P. Hagins et al. · Open Forum Infectious Diseases
Open access |
27 Nov 2023 |
6 |
| 40 |
Subcutaneous Lenacapavir in People With Multidrug-Resistant HIV-1: 156 Week Results of the CAPELLA Study
Onyema Ogbuagu, ANDREW A. WIZNIA, Joseph P. McGowan et al. · Open Forum Infectious Diseases
Open access |
16 Dec 2025 |
5 |
| 41 |
Impact of Treatment Adherence on Efficacy of Dolutegravir + Lamivudine and Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Week 144 Analysis of the GEMINI-1 and GEMINI-2 Clinical Studies
Eva Fernvik, Juan Sierra Madero, Núria Espinosa et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes
|
18 Oct 2023 |
5 |
| 42 |
Immunization Registries: Provider Recruitment and Participation
Marianne Pappas, Barbara Baker, Debbie Appelbaum et al. · American Journal of Preventive Medicine
|
Mar 1997 |
5 |
| 43 |
‘I Will Not Leave My Baby Behind’: A Cook Island Māori Family's Experience of New Zealand Māori Traditional Healing
Wiremu NiaNia, Tere, Allister Bush et al. · Australian and New Zealand Journal of Family Therapy
|
Mar 2013 |
5 |
| 44 |
The Surgical Sisterhood – The Experiences of wāhine Māori and Pasifika Aspiring Surgeons
Senitila Tutone, Atua Fuimaono-Asafo, Ailsa Wilson et al. · Qualitative Health Research
|
20 Dec 2022 |
4 |
| 45 |
155. Long-Acting Subcutaneous Lenacapavir in People with Multi-Drug Resistant HIV-1: 3-Year Results of the CAPELLA Study
Onyema Ogbuagu, Joseph P. McGowan, Ann E. Stapleton et al. · Open Forum Infectious Diseases
Open access |
29 Jan 2025 |
3 |
| 46 |
1251. 5-year outcomes of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as initial treatment of HIV-1 in adults with high baseline HIV-1 RNA and/or low CD4 count in two Phase 3 randomized clinical trials
Moti N. Ramgopal, Anson K Wurapa, Axel Baumgarten et al. · Open Forum Infectious Diseases
Open access |
Dec 2022 |
3 |
| 47 |
Diagnostic Chelation Challenge with DMSA: A Biomarker of Long-Term Mercury Exposure?
Howard Frumkin, Claudine C. Manning, Phillip L. Williams et al. · Environmental Health Perspectives
Open access |
Feb 2001 |
3 |
| 48 |
A cutaneous rash with mixed gell coombs allergic features, sclerodermoid changes and status post previous therapy
Ana María Abreu Vélez, Josepha Devaro, Michael S. Howard · Our Dermatology Online
Open access |
2 Oct 2017 |
3 |
| 49 |
A Simulated-Field Method of Testing Residual Insecticide Deposits Against Cockroaches1
Arthur D. Flynn, H. F. Schoof · Journal of Economic Entomology
|
Feb 1966 |
3 |
| 50 |
1046. Week 48 Outcomes from the BRAAVE 2020 Study: A Randomized Switch to B/F/TAF in African American Adults with HIV
Debbie P. Hagins, Princy N. Kumar, Michael S. Saag et al. · Open Forum Infectious Diseases
Open access |
Oct 2020 |
2 |